Viburnum Opulus 1 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02234796) held by Dolisos Canada Inc., containing Viburnum Opulus. Health Canada lists its status as Cancelled Post Market (status date 20 Apr 2006). Nexara Health has matched 10 registrations of Viburnum Opulus across 2 other regulated markets.
Health Canada registration
| DIN | 02234796 |
|---|---|
| Brand name | Viburnum Opulus |
| Active ingredient | Viburnum Opulus |
| Strength | 1 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 20 Apr 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Viburnum Opulus registered in other markets
10 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Viburnum opulus | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Viburnum opulus | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Viburnum Opulus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Viburnum Opulus worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Viburnum Opulus (DIN 02234796) marketed in Canada?
No. Health Canada lists DIN 02234796 as Cancelled Post Market as of 20 Apr 2006.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Viburnum Opulus registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234796, status date 2006-04-20; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234796, status date 2006-04-20; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02234796, status date 2006-04-20; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.